AstraZeneca Agrees Last-Minute $50m Settlement In Seroquel XR Delay Case
ANDA Filer Handa Also Pens Much Smaller Settlement; Follows Six Years Of Litigation
A class action suit alleging AstraZeneca delayed generic competition for Seroquel XR by making illegal agreements that stifled market entry for generic quetiapine competitors has been dismissed after the originator agreed to settle for tens of millions of dollars.
